Ultrasound study reveals stomach risks for patients on popular diabetes drugs
NCT ID NCT06003985
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study used a simple bedside ultrasound to check if patients taking GLP-1 agonist drugs (like Ozempic or Mounjaro) have more food or liquid in their stomach before surgery compared to those not on these drugs. Researchers enrolled 354 adults and looked for signs of delayed stomach emptying. The goal is to better understand if these medications increase the risk of complications during anesthesia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GLP-1 agonists (semaglutide, dulaglutide, tirzepatide)
What this could lead to
If successful, this could help doctors know if GLP-1 drugs increase the risk of having food in the stomach during surgery, which could improve safety guidelines.
What could go wrong
This is a small, completed observational study, not a treatment trial. It only measures stomach contents with ultrasound, so it cannot prove cause and effect or change practice on its own.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POINT-OF-CARE ULTRASOUND are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Albany Medical Center
Albany, New York, 12208, United States
-
George Washington University Hospital
Washington D.C., District of Columbia, 20037, United States
-
Hospital for Special Surgery
New York, New York, 10021, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
University Health Network
Toronto, Ontario, M5G 2C4, Canada
-
University of Virginia
Charlottesville, Virginia, 22903, United States
-
Weill Cornell Medicine
New York, New York, 10065, United States